1
|
Zuckermann A, Jacobs J, Shudo Y, Meyer D, Silvestry S, Leacche M, Sciortino C, Rodrigo M, Pham S, Takeda K, Copeland H, Vidic A, Kawabori M, Boston U, Bustamante-Munguira J, Esteve AE, Venkateswaran R, Schroder J, D'Alessandro D. Validating the 2014 Consensus Primary Graft Definition: An Analysis on the 1,056 Patients from the Multi-Center Guardian Registry. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
2
|
Bing M, Shedd C, Lwin H, Kaza V, Bollineni S, Mahan L, Mohanka M, Lawrence A, Joerns J, Wait M, Peltz M, Huffman L, Hackmann A, Iacono A, Heid C, Torres F, Pham S, Timofte I. Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
3
|
Balasubramanian P, Thomas M, Makey I, Alvarez F, Narula T, Pham S, Landolfo K, Ahmed MES, Jacob S, Shah S, Mallea J. Remote vs Local Ex-Vivo Lung Perfusion, a Single Center Experience. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.1441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Hussain M, Yazji J, Garg P, Wadiwala I, Alamouti-Fard E, Alomari M, Jacob S, Edwards M, Pham S. Bariatric Surgery is Safe and Effective in Thoracic Organ Transplant Recipients. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
5
|
Stehlik J, Schroder J, Pinney S, Patel C, D'Alessandro D, Goldstein D, Jorde U, Patel S, Mani D, Esmailian F, Kobashigawa J, Takeda K, Uriel N, Pham S, Patel P, Kai M, Sun B, Shah A, Ono M, Couper G, DeNofrio D, Vest A, Joyce D, DeVore A, Mallidi H, Itoh A, Mehra M, Givertz M, Milano C, Farr M. First Report of the Transmedics Organ Care System Heart Perfusion Registry. A Multi-Institutional Outcomes Analysis. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
6
|
Jang J, Ruiz J, Desai S, Sareyyupoglu B, Paghdar S, Malkani S, Landolfo K, Patel P, Nativi J, Yip D, Lyle M, Leoni J, Pham S, Goswami R. Mid-Term Survival in Patients with Advanced Heart Failure Receiving an Impella Device Intended as Bridge to Transplantation. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
7
|
Milano C, Schroder J, Farr M, DeVore A, D'Alessandro D, Goldstein D, Jorde U, Patel S, Daneshmand M, Pinney S, Esmailian F, Kobashigawa J, Takeda K, Uriel N, Pham S, Patel P, Kai M, Sun B, Shah A, Ono M, Couper G, DeNofrio D, Vest A, Joyce D, Mallidi H, Itoh A, Mehra M, Givertz M, Patel C, Stehlik J. Demographics and Outcomes of Clinical Trial vs Initial Post-Approval Use of Transmedics Organ Care System Heart. J Heart Lung Transplant 2023. [DOI: 10.1016/j.healun.2023.02.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
8
|
Schroder J, Shah A, Pretorius V, Smith J, Daneshmand M, Geirsson A, Pham S, Um J, Silvestry S, Shaffer A, Mudy K, Kai M, Joyce D, Philpott J, Takeda K, Goldstein D, Shudo Y, Couper G, Mallidi H, Esmailian F, Pham D, Salerno C, Lozonschi L, Quader M, Patel C, DeVore A, Bryner B, Madsen J, Absi T, Milano C, D'Alessandro D. Expanding Heart Transplants from Donors After Circulatory Death (DCD) - Results of the First Randomized Controlled Trial Using the Organ Care System (OCS™) Heart - (OCS DCD Heart Trial). J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.165] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
9
|
Wettstein M, Berlin A, Pham S, Sridhar S, Chung P, Shabbir A, Van Der Kwast T, Qadri S, Li K, Liu N, Hermanns T, Kukarni G. Trimodal therapy versus radical cystectomy for T2 bladder cancer: real-world evidence from Ontario. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00846-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
10
|
Diefenbach C, Budde E, Chavez J, Lossos IS, Mehta A, Dorritie K, Kamdar M, Negricea R, Pham S, Hristopoulos M, Huw LY, Hear CO, Oki Y, To I, Ghosh N. PROMISING CLINICAL DATA FROM DOSE ESCALATION IN A PHASE IB/II ONGOING STUDY OF MOSUNETUZUMAB WITH POLATUZUMAB VEDOTIN FOR RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.154_2880] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
11
|
Chorba JS, Shapiro AM, Le L, Maidens J, Prince J, Pham S, Kanzawa MM, Barbosa DN, Currie C, Brooks C, White BE, Huskin A, Paek J, Geocaris J, Elnathan D, Ronquillo R, Kim R, Alam ZH, Mahadevan VS, Fuller SG, Stalker GW, Bravo SA, Jean D, Lee JJ, Gjergjindreaj M, Mihos CG, Forman ST, Venkatraman S, McCarthy PM, Thomas JD. Deep Learning Algorithm for Automated Cardiac Murmur Detection via a Digital Stethoscope Platform. J Am Heart Assoc 2021; 10:e019905. [PMID: 33899504 PMCID: PMC8200722 DOI: 10.1161/jaha.120.019905] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Background Clinicians vary markedly in their ability to detect murmurs during cardiac auscultation and identify the underlying pathological features. Deep learning approaches have shown promise in medicine by transforming collected data into clinically significant information. The objective of this research is to assess the performance of a deep learning algorithm to detect murmurs and clinically significant valvular heart disease using recordings from a commercial digital stethoscope platform. Methods and Results Using >34 hours of previously acquired and annotated heart sound recordings, we trained a deep neural network to detect murmurs. To test the algorithm, we enrolled 962 patients in a clinical study and collected recordings at the 4 primary auscultation locations. Ground truth was established using patient echocardiograms and annotations by 3 expert cardiologists. Algorithm performance for detecting murmurs has sensitivity and specificity of 76.3% and 91.4%, respectively. By omitting softer murmurs, those with grade 1 intensity, sensitivity increased to 90.0%. Application of the algorithm at the appropriate anatomic auscultation location detected moderate‐to‐severe or greater aortic stenosis, with sensitivity of 93.2% and specificity of 86.0%, and moderate‐to‐severe or greater mitral regurgitation, with sensitivity of 66.2% and specificity of 94.6%. Conclusions The deep learning algorithm’s ability to detect murmurs and clinically significant aortic stenosis and mitral regurgitation is comparable to expert cardiologists based on the annotated subset of our database. The findings suggest that such algorithms would have utility as front‐line clinical support tools to aid clinicians in screening for cardiac murmurs caused by valvular heart disease. Registration URL: https://clinicaltrials.gov; Unique Identifier: NCT03458806.
Collapse
|
12
|
D'Alessandro D, Philpott J, Boeve T, Pham S, Zuckermann A. First Report of the GUARDIAN Registry: An International Consortium Examining the Effect of Controlled Hypothermic Preservation in Heart Transplantation. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.398] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
13
|
Wettstein M, Baxter N, Sutradhar R, Mamdani M, Pham S, Qadri S, Bhalla G, Li K, Liu N, Van Der Kwast T, Hermanns T, Kulkarni G. Predictors of re-resection in primary T1 bladder cancer: Identifying patients who do not receive guideline-concordant care at the population level. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33538-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
14
|
Stinson G, Patel P, Yip D, Leoni-Moreno J, Ung R, Landolfo K, Pham S, Sareyyupoglu B, Goswami R. Assessment of Aortic Root Size in Donor Heart Predicts Short and Long Term Recipient Outcomes after Orthotopic Heart Transplantation. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.587] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
15
|
Jones E, Pham S, Banka L, Scott L, Kwong K. M452 SPECIFIC ANTIBODY DEFICIENCY MASQUERADING AS ALLERGIC FUNGAL RHINOSINUSITIS. Ann Allergy Asthma Immunol 2019. [DOI: 10.1016/j.anai.2019.08.445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Febvre M, Souidi A, Fallet V, Sanchis Borja M, Izadifar A, Baud M, Pham S, Didier M, Cadranel J. [Mediastinitis after endobronchial ultrasound-guided transbronchial needle aspiration: Should we modify our practices?]. Rev Mal Respir 2018; 35:1063-1064. [PMID: 30554592 DOI: 10.1016/j.rmr.2018.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2018] [Accepted: 05/30/2018] [Indexed: 11/26/2022]
|
17
|
Fideli U, Agbor-Enoh S, Gorham S, Jang M, Yang Y, Bhatti K, Marishta A, Rodrigo M, Najjar S, Shah K, Russell S, Pham S, Feller E, Shah P, Valantine H. Genomic Research Alliance for Transplantation (GRAfT) A Unique Cohort to Address Age, Sex and Race in Heart Transplants. J Heart Lung Transplant 2017. [DOI: 10.1016/j.healun.2017.01.1140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
18
|
Kim J, Barr E, Terrin M, Timofte I, Sanchez P, Kon Z, Pierson R, Wijesinha M, Pham S, Iacono A. Change in Body Mass Index at Listing from Primary Transplant to Re-Transplantation Predicts Re-Transplant Survival. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
19
|
Timofte I, Terrin M, Wijesinha M, Sanchez P, Pierson R, Barr E, Kim J, Kon Z, Pham S, Iacono A. Pulmonary Hypertension in COPD: A Survival Analysis of Patients Listed for Lung Transplantation. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
20
|
Agbor-Enoh S, Fideli U, Doveikis J, Zhu J, Tunc I, Shah P, Russell S, Feller E, Shah K, Rodrigo M, Shah P, Pham S, Iacono A, Nathan S, Orens J, GRAfT Investigators N, Valantine H. Genomic Research Alliance for Transplantation (GRAfT): A Model for Long Term Transplant Studies in Thoracic Organ Transplantation. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
21
|
Pham S, Arampulikan J, Ruiz D, Resnick N. Safety and efficacy of transradial uterine fibroid embolization via small caliber arterial access. J Vasc Interv Radiol 2016. [DOI: 10.1016/j.jvir.2015.12.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
22
|
Boitiaux J, Pham S, Gosset-Woimant M, Sénéchal F, Philippe B. Sarcoïdose avec manifestations initiales sévères : quelle évolution ? Rev Mal Respir 2016. [DOI: 10.1016/j.rmr.2015.10.234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
23
|
Samain C, Lévy P, Boitiaux J, Gosset-Woimant M, Pham S, Sénéchal F, Philippe B. Influence de la prise préalable d’anti-inflammatoires non stéroïdiens sur la présentation et l’évolution de pneumonies aiguës communautaires hospitalisées. Rev Mal Respir 2015. [DOI: 10.1016/j.rmr.2014.11.039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Guimber D, Dauchet L, Bouteloup C, Danel N, Darmon P, de Luca A, Turquet A, Pham S, Quilliot D, Raynard B, Gower C, Hennequin V, Lescut D. P173 Incidence et prévalence de la nutrition entérale à domicile (NED) chez l’enfant en France. NUTR CLIN METAB 2013. [DOI: 10.1016/s0985-0562(13)70505-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
25
|
Salgar SK, Manning E, Li S, Vazquez-Padron R, Mathew J, Ruiz P, Pham S. Interleukin-10 delivery via mesenchymal stem cells (MSC) to prevent ischemia/reperfusion injury in lung transplantation (141.46). THE JOURNAL OF IMMUNOLOGY 2009. [DOI: 10.4049/jimmunol.182.supp.141.46] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
Ischemia-reperfusion injury (IR) is an important cause for lung graft loss (~30%). In this study, MSC & viral interleukin-10 (vIL-10) engineered MSC were tested for their ability to prevent lung IR injury. Bone marrow derived MSC from Lewis rat were transduced with rvIL-10-retrovirus & selected on neomycin. Following 120 min of left lung ischemia induction, Group A, rats received vIL-10-MSC (~15 x 106; i.v.); Group B, empty vector engineered MSC; Group C, MSC; Group D, saline; and Group E, no ischemia or MSC. Mean blood oxygenation (PaO2/FiO2 ratio, mmHg) was reduced (P<0.05) at 24h post-IR injury in Group B (138±86; n=9) & Group D (87±39; n=10), compared to MSC-vIL10 (353±105; Group A; n=10) group. By days 3 & 7 with MSC-vIL10 oxygenation was normal (475±55 & 435±33; n>9); by 4h it was 319±94 (n=7). MSC (passage ≤6) increased PaO2/FiO2 (454 ± 59; n=5) by 24h post-IR. Bronchoalveolar lavage at 24h post-MSC-vIL10 therapy reduced (P<0.05) granulocytes, CD4 & CD8 T cells. Lung injury score (histopathology) was higher (P<0.05) with no treatment (3.5 ± 1.3; n=5) compared to MSC-vIL10 (1.21± 0.6; n=7) & MSC (1.6±0.9; n=6) treated groups. Lung microvascular permeability & wet:dry ratio were lower (P<0.05) in MSC-vIL10 group. IL-1α, MCP-1α, MIP-1α, & IL1-β were increased in IR injured lung. ISOL (in situ staining for DNA fragmentation) & CASPACE-3 demonstrated reduced (p<0.05) number of apoptotic cells in MSC-vIL10 treated lungs. Ex vivo, expanded MSC were CD34-, CD31+ & CD45+ (5-10%), CD29+, CD90+ & CD44+ (65-95%), CD80 (0%), CD 86 (8%), MHC Class I+ (23-57%), & MHC Class II-. MSC & IL-10 delivery via MSC to prevent lung transplant IR injury seems promising.
Collapse
|